All posts tagged "Biotechnology"
-
101Stocks NewsBreaking: Xenon Pharmaceuticals Stock Surges Past $56.39 Analyst Target Price
VANCOUVER, British Columbia — March 10, 2026: In a significant market development, shares of Xenon Pharmaceuticals Inc (NASDAQ: XENE) surged past the...
-
106Stocks News
ADC Therapeutics Beats Q4 Estimates with 55% Earnings Surprise
LAUSANNE, Switzerland — March 3, 2022: ADC Therapeutics SA (NYSE: ADCT) reported fourth-quarter 2021 financial results this morning, revealing a narrower-than-expected loss...
-
105Stocks News
Opus Genetics Q4 Earnings: Loss Widens But Revenue Beats by 47%
RALEIGH, N.C. — March 10, 2026: Opus Genetics, Inc. (NASDAQ: IRD) reported mixed fourth-quarter results this morning that revealed a widening loss...
-
114Stocks News
Breaking: Revvity (RVTY) Hits Oversold Zone as RSI Plunges to 29.8
NEW YORK, March 10, 2026 — Revvity Inc. (NYSE: RVTY) entered technically oversold territory during Tuesday’s trading session, with its Relative Strength...
-
101Stocks News
Editas Medicine Q4 Results: Narrower Loss, Revenue Beat Signals Genome Editing Progress
CAMBRIDGE, Mass. — February 24, 2022: Editas Medicine Inc. (NASDAQ: EDIT), the pioneering genome editing company, reported fourth-quarter 2021 financial results that...
-
100Stocks News
Breaking: ARS Pharmaceuticals (SPRY) Posts Q4 Loss But Delivers Critical Revenue Beat
San Diego, California — March 9, 2026: ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) reported mixed fourth-quarter results this morning, posting a loss that...
-
111Stocks News
Breaking: Guardant Health (GH) Plunges into Oversold Territory – RSI Hits 24.0
On Friday, May 6, 2022, shares of Guardant Health Inc (NASDAQ: GH), a leading precision oncology company based in Redwood City, California,...
-
104Stocks News
Breaking: Mbx Biosciences Hits Oversold Territory with Critical 29.1 RSI Reading
INDIANAPOLIS, March 9, 2026 — Shares of Mbx Biosciences Inc (NASDAQ: MBX) entered technically oversold territory during Monday’s trading session, triggering potential...
-
112Stocks News
Breaking: Gilead Sciences (GILD) Stock Surges, Outpacing S&P 500 – Key Analysis
NEW YORK, March 9, 2026 — Shares of Gilead Sciences, Inc. (GILD) closed Monday’s trading session at $146.63, marking a significant single-day...
-
288AI
Biotech Startups Revolutionize Healthcare: 9 Innovative Innovations from StockPil’s Startup Battlefield 2025
San Francisco, October 2025 – StockPil’s prestigious Startup Battlefield competition has once again identified the most promising biotechnology ventures likely to transform...
